Ernest S. Smith,Maurice Zauderer,William J. Bowers,Alan Jonason
申请号：
US16460593
公开号：
US10800853B2
申请日:
2019.07.02
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Provided herein are methods for alleviating symptoms in a subject having a neurodegenerative disorder, comprising administering to the subject an effective amount of an isolated binding molecule which specifically binds to semaphorin-4D (SEMA4D) or to its Plexin-B1 or Plexin-B2 receptors.
